Fetal Stem Cell Extracellular Vesicles for Innate Immunity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccines and antibody therapies primarily activate the adaptive immune system to prevent or treat infectious diseases, neglecting the innate immune system, which deteriorates after birth and lacks effective activation methods.
Innovation Solution
Development of fetal stem cell-derived extracellular vesicles containing immunoglobulins such as IgG3, IgM, IgA, IgD, and IgE, produced under culture conditions mimicking pregnancy, to enhance innate immunity by promoting the secretion and expression of natural antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current vaccines and antibody therapies are used to prevent or treat infectious diseases, then the adaptive immune system is activated, but the innate immune system deteriorates after birth and lacks effective activation methods
Solution Approach 1:
The patent uses fetal stem cell-derived extracellular vesicles as an intermediary carrier to deliver natural antibodies (IgM, IgG3, IgA, IgD, IgE) to the host system. These vesicles act as a bridge between the innate and adaptive immune systems, enabling activation of innate immunity without direct vaccination approaches. The vesicles protect the immunoglobulins during delivery and facilitate their integration into the host's immune response mechanism.
Solution Approach 2:
The patent employs immunoglobulins produced during fetal development (natural antibodies) as a preliminary immune defense mechanism. These pre-formed antibodies are encapsulated in extracellular vesicles before administration, providing immediate innate immune protection upon delivery, rather than requiring time for the host to develop adaptive immunity responses.
2Quantity of substance
If fetal stem cells are cultured under conditions mimicking pregnancy to produce extracellular vesicles with immunoglobulins, then natural antibodies are secreted and expressed, but complex culture conditions including temperature change and vibration are required
Solution Approach 1:
The patent utilizes physiological temperature fluctuations (mimicking maternal body temperature changes during pregnancy) and mechanical vibration parameters to stimulate fetal stem cells to secrete extracellular vesicles rich in immunoglobulins. By controlling these physical parameters, the system achieves high concentrations of natural antibodies without requiring complex biochemical culture media or growth factors.
Solution Approach 2:
The fetal stem cells are induced to self-produce and self-secret e extracellular vesicles containing immunoglobulins under simulated physiological conditions. The cells naturally express and secrete the five types of immunoglobulins (IgM, IgG3, IgA, IgD, IgE) without requiring external addition of these proteins, leveraging the cells' inherent biological capabilities.
3Adaptability or versatility
If extracellular vesicles containing all five types of immunoglobulins are produced, then comprehensive innate immunity is enhanced, but the production process requires specific culture conditions with temperature change and vibration
Solution Approach 1:
The patent produces a single type of extracellular vesicle that simultaneously contains all five types of immunoglobulins (IgM, IgG3, IgA, IgD, IgE), providing comprehensive coverage against various pathogens including bacteria, viruses, fungi, and parasites. This multi-functional vesicle formulation eliminates the need for separate production and combination of different antibody therapies.
Solution Approach 2:
The culture process employs periodic temperature changes (mimicking circadian rhythm and maternal body temperature variations) and rhythmic vibration to stimulate continuous secretion of extracellular vesicles. This periodic stimulation maintains high production levels of immunoglobulins throughout the culture period without requiring constant intervention or media changes.
Data Source
AI summary
A fetal stem cell-derived extracellular vesicle has immune tolerance properties. The extracellular vesicle containing a fetal stem cell-derived primal immunoglobulin contains various natural antibodies and complement proteins which can immediately respond to foreign infectious agents such as viruses, bacteria, pathogens, etc., and thus can effectively treat and prevent infectious diseases through an enhanced innate immune system. Methods are disclosed for preparing the fetal stem cell-derived extracellular vesicle.


